SCHEMBL7103068

SCHEMBL7103068

C1OCC2=C1O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16569192 0.60
SCHEMBL16179067 0.57
SCHEMBL2780812 0.57
SCHEMBL141953 0.57
SCHEMBL2788228 0.55
SCHEMBL14606241 0.55
SCHEMBL10770584 0.55
SCHEMBL5378417 0.55
Dioxane SCHEMBL7554059 0.46
Oxirane SCHEMBL11492072 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994882-B1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS DU PONT (US) 2003-09-10 EP claimed
US-6207847-B1 REACTING AN EPOXIDE WITH AN AZIDOTRIMETHYLSILANE; THEN HYDROCARBON HALIDE E. I. DU PONT DE NEMOURS AND COMPANY 2001-03-27 US claimed
EP-0994882-A1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2000-04-26 EP claimed
WO-1999002535-A1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-01-21 WO claimed
EP-0994882-B1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS DU PONT (US) 2003-09-10 EP disclosed
US-6207847-B1 REACTING AN EPOXIDE WITH AN AZIDOTRIMETHYLSILANE; THEN HYDROCARBON HALIDE E. I. DU PONT DE NEMOURS AND COMPANY 2001-03-27 US disclosed
EP-0994882-A1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2000-04-26 EP disclosed
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
WO-1999002535-A1 MANUFACTURE OF OPTICALLY ACTIVE HALOHYDRIN TRIALKYLSILYL ETHERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-01-21 WO disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
EP-0683772-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1995-11-29 EP disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
EP-0683772-A4 RETROVIRAL PROTEASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1995-09-27 EP disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed
US-5086189-A PROCESS FOR THE MANUFACTURE OF EPOXIDES INTEROX (SOCIETE ANONYME) (BE) 1992-02-04 US disclosed
EP-0068564-A1 Process for the preparation of epoxides INTEROX Société Anonyme (BE) 1983-01-05 EP disclosed